A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery

NCT04829916 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Kidney Injury (AKI)

Interventions

DRUG: RMC-035
DRUG: Placebo

Sponsor

Guard Therapeutics AB